The IFB is the National Bioinformatics Infrastructure that provides support, deploys services, organizes training and carries out innovative developments for the life sciences communities.
Évry, France
251-500 Employees
Medium-Sized
Working industry
IT, Software and Services
Type of company
Service provider, Educational institution
Ownership structure
Educational Institution
Locations
1 Headquarter
Specialised areas
Agri-food, Biology, Environment, Biotechnology, IT, Cloud Computing, Information Technology & Services
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
France
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Institut Français de Bioinformatique operates in 1 country around the world
Get an overview of the locations of Institut Français de Bioinformatique
Location
Country
State
City
Headquarter
France
Bourgogne-Franche-Comté
Évry
Some frequent questions that have been asked about Institut Français de Bioinformatique
Where is Institut Français de Bioinformatique located?
The company headquarter of Institut Français de Bioinformatique is located in Évry, Bourgogne-Franche-Comté, France. It's worth noting, that the company may have more locations
How many employees does Institut Français de Bioinformatique approximately have?
As of the latest available information Institut Français de Bioinformatique has around 251-500 employees worldwide.
In which industries does Institut Français de Bioinformatique mainly work?
The company Institut Français de Bioinformatique has it's main focus in the industries of IT, Software and Services
What is the current company status of Institut Français de Bioinformatique?
Based on the founding year and the amount of employees the company Institut Français de Bioinformatique seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to Institut Français de Bioinformatique
NBIS – National Bioinformatics Infrastructure Sweden
Uppsala, Sweden
51-100 Employees
2016
NBIS (National Bioinformatics Infrastructure Sweden) provides bioinformatics and data science support to the Swedish life science research community since 2008. We provide a wide spectrum of services, including advanced bioinformatics analysis, bioimage informatics, data management, imaging AI support, systems and tools development, and support to national compute resources. NBIS is a national research infrastructure which comprises ~120 experts in different fields, distributed across six sites in Sweden: Lund, Gothenburg, Linköping, Stockholm, Uppsala and Umeå. NBIS constitutes the SciLifeLab Bioinformatics platform and forms the Swedish node in ELIXIR (the European infrastructure for biological information). NBIS is working in close collaboration with other SciLifeLab platforms and other national infrastructures, the SciLifeLab Data Centre, the National Academic Infrastructure for Supercomputing in Sweden (NAISS), and many other stakeholders and collaborators to create synergies and provide the most optimal services to the research community. NBIS offers opportunities for specialists in different domains of bioinformatics. We provide expert knowledge and bioinfomatics support, innovative data integration, advanced training, efficient data publication for open science, and access to high-performance data analysis methods. NBIS is the Swedish node in ELIXIR - the European infrastructure for life sciences research.
Irish Bioeconomy Foundation
Lisheen, Ireland
1-10 Employees
2017
Our mission is to promote the conversion of Ireland’s natural land & sea resources to high value products for the development of a sustainable bioeconomy that is globally competitive and creates local development. IBF will soon operate a modern Bioprocess pilot plant covering 1,700 sq. Support in confidential fundraising while leveraging IBF established International networks and relationships. Support in positioning and promoting your products, processes and brand within the Irish and EU Bioeconomy arena.
International Federation of Biosafety Associations
Ottawa, Canada
51-100 Employees
2001
We are a global community of certified biorisk management professionals, biosafety officers, scientists, laboratory personnel, architects, engineers, academics and policy makers who have common interest in safe, secure and responsible work with biological materials. We are a global community of certified biorisk management professionals, scientists, laboratory personnel, architects, engineers, academics and policy makers who have a common interest in advancing biosafety and biosecurity. The International Federation of Biosafety Associations (IFBA) is a not-for-profit non-governmental organization of regional and national Biosafety Associations from all areas of the world. IFBA What we Do IFBA Mission Statement Strengthening Global Health Security: The Role of Biosafety Professional Associations Biosafety and Global Public Health IFBA 5 Year Strategic Plan – A Vision of Tomorrow.
IBISBA
Toulouse, France
51-100 Employees
2017
IBISBA is a pan-European distributed research infrastructure dedicated to industrial biotechnology. Moreover, IBISBA is designed to meet 21st century science and technology challenges, providing the depth of pan-European cooperation required to harness the opportunities offered by powerful digital technologies, such as artificial intelligence. In this regard, IBISBA helps to reach EuropaBio’s projections, which anticipate that Europe’s industrial biotechnology will grow to up to 900,000-1,500,000 jobs in 2030. We provide a single access point to integrated services for end-to-end bioprocess development. IBISBA is a pan-European research infrastructure dedicated to Industrial Biotechnology. We provide a single access point to researchers from academia and industry across the globe to integrated services for end-to-end bioprocess development. In doing so, IBISBA accelerates the production and translation of cutting-edge knowledge into innovation for biomanufacturing. We develop smart biomanufacturing by integrating biotechnology with AI, digital twins and cloud technologies.
Interuniversity Institute of Bioinformatics in Brussels
Brussels, Belgium
11-50 Employees
2013
The goal of the (IB)² is to bring together research groups in and around Brussels requiring bioinformatics and computational biology expertise. (IB)² is an interuniversity, cross-faculty (Medicine, Sciences, and Applied Sciences) collaborative space located on the La Plaine campus of the Université Libre de Bruxelles. Increasing the impact of bioinformatics research by bringing together experts from different fields to tackle various (bio) medical problems with the aim to advance fundamental research as well as assist clinicians in helping patients. Enable interdisciplinary and interuniversity research collaborations in bioinformatics by providing a physical location for research, meetings, collaborations, seminars as well as high-performance computer facilities, including the ULB-VUB computing center. Allow Technology Transfer through training, education, innovation and collaborations. The (IB)² has the ambition to evolve into a competitive structure of scientific excellence, recognized at national and international level.
BioInfoBank Institute
Poland
11-50 Employees
2000
Our mission is to create, inspire and incubate innovative ideas in life-sciences. The main scientific focus of the institute is bioinformatics, an inter-disciplinary field of science driven by achievements in biotechnology and information technology. The fourth research area is the design of application specific integrated circuits (ASICs). The results of our work are worldwide innovative technological and biomedical solutions. Some of them are converted into commercial projects that can be disseminated across the BioInfoBank network and developed through a spin-off program.